RegStem (autologous mesenchymal stromal cell therapy)
/ EMO Biomedicine Corp
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 14, 2019
Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stromal Cell Product (RegStem)
(clinicaltrials.gov)
- P1; N=12; Completed; Sponsor: EMO Biomedicine Corporation; Recruiting ➔ Completed
Clinical • Trial completion
1 to 1
Of
1
Go to page
1